Q&A: Vertex’s pain research chief on moving beyond opioids, AI and how pharma acquisitions thrive or fail

SAN DIEGO — For savvy deal­mak­ing, Ver­tex’s 2001 ac­qui­si­tion of Au­ro­ra Bio­sciences is near the top of the list.

Ver­tex bought the San Diego biotech for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.